1. OC-0257 Impact of RT dose and fractionation on biomarkers of systemic immune responses in early stage NSCLC. (May 2022) Authors: Gkika, E.; Firat, E.; Adebahr, S.; Popp, I.; Radicioni, G.; Exner, J.; Rühle, A.; Sprave, T.; Nestle, U.; Nicolay, N.; Niedermann, G.; Duda, D.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-0874 Impact of dose and prescription method in SBRT of NSCLC. A pooled analysis of 2 prospective trials. (August 2021) Authors: Gkika, E.; Adebahr, S.; Radicioni, G.; Exner, J.; Haehl, E.; Spohn, S.; Rühle, A.; Zamboglou, C.; Nicolay, N.; Sprave, T.; Wiehle, R.; Baltas, D.; Nestle, U.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1227 Impact of inflammation using blood parameters in HCC patients treated with SBRT. (August 2021) Authors: Radicioni, G.; Exner, J.H.; Adebahr, S.; Haehl, E.; Spohn, S.; Rühle, A.; Zamboglou, C.; Nicolay, N.H.; Sprave, T.; Grosu, A.; Gkika, E. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1556: 4D-PET radiomics-features for radiotherapy treatment monitoring in locally advanced NSCLC patients. (November 2020) Authors: Carles, M.; Fechter, T.; Benndorf, M.; Radicioni, G.; Schimek Jasch, T.; Adebahr, S.; Baltas, D.; Grosu, A.L.; Mix, M.; Nestle, U.; Gkika, E. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗